Original Article
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 21, 2014; 20(47): 17877-17882
Published online Dec 21, 2014. doi: 10.3748/wjg.v20.i47.17877
Table 2 Clinical characteristics of chronic hepatitis C patients treated with or without interferon
IFN (-),n = 35IFN (+),n = 54P value
Age60.0 ± 12.356.4 ± 9.20.1112
SexM:17; F:18M:27; F:270.6351
Duration of IFN therapy (wk)NA22.3 ± 17.4NA
HCV RNA (Log IU/mL)6.0 ± 1.31.2 ± 2.0< 0.0001
ALT (U/L)60.5 ± 52.633.4 ± 26.20.0017
ALP (U/L)307.0 ± 108.0265.2 ± 77.20.0360
GGT (U/L)48.9 ± 37.4145.4 ± 44.30.6981
T-Bil (mg/dL)0.86 ± 0.280.85 ± 0.440.9323
Alb (g/dL)4.19 ± 0.404.15 ± 0.440.6315
PLT (× 104/μL)14.5 ± 5.113.1 ± 6.90.2938
PT84.2% ± 7.5%86.0 ± 10.10.7966